Geron Corporation - Common Stock — 재무제표 (NASDAQ:GERN)

Financials

총자산 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M 총 부채 59.78 M99.62 M110.58 M146.13 M313.46 M344.67 M 자본금 총액 210.95 M126.42 M80 M247.95 M280.32 M225.87 M 총 부채 및 주주자본 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M 총부채 24.04 M49.83 M51.16 M81.94 M165.37 M119.55 M 순부채 24.04 M49.83 M51.16 M81.94 M165.37 M41.99 M

Geron Corporation - Common Stock

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

GERN

Financials

Geron Corporation - Common Stock

뉴스

Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

Geron Corp, Barclays 헬스케어 컨퍼런스 발표: 성장 전략 및 향후 계획

Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans

Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?

게론, TD 카우en 컨퍼런스: 전략적 성장 및 시장 확대

Geron at TD Cowen: Strategic Growth and Market Expansion

Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)

Geron Corporation (GERN) Q4 2025 Earnings Call Transcript

Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates